Alychlo
VC Fund
Alychlo is a VC fund focused on CRM and Energy. Alychlo
- Total investments:
- 9
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Alychlo invests in
Stages Alychlo invests in
Countries Alychlo invests in
Round sizes
Round size
- Series D
- $30M–$32M
- Venture - Series Unknown
- $12M–$18M
Investment Focus
Industry
- CRM 1 (11%)
- Energy 1 (11%)
- Rental 1 (11%)
- Banking 1 (11%)
- FinTech 1 (11%)
Stage
- Series D 2 (22%)
- Venture - Series Unknown 2 (22%)
- Series A 1 (11%)
- Series E 1 (11%)
- Funding Round 1 (11%)
Country
- Belgium 4 (44%)
- United States 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lizy
|
Lizy provides SME and professional leasing solutions that are simple, quick, and inexpensive. LIZY wants to take the hassle out of leasing by offering transparent all-in prices, flexible contracts, and a selection of young, high-quality used cars that are immediately available. Sam Heymans and Vincent Castus, two young entrepreneurs, founded LIZYin 2019. | $11.7M / Venture - Series Unknown / Aug 26, 2026 | |
banqUP
|
BanqUP is an API-driven platform for open banking solutions, allowing for banks and fintech companies to access a number of European banking APIs. BanqUP helps TPPs and banks quickly access open banking ecosystem and analyze banking data, allowing them to create bold and innovative solutions, as well as cross-sell and up-sell their existingproducts. | $6.5M / Debt Financing / Jan 26, 2026 | |
miDiagnostics
|
miDiagnostics is developing a new generation of disposable tests that require only drops of blood and allow detection of cells, proteins, nucleic acids, and/or small molecules. | $31.5M / Series D / Dec 04, 2024 | |
|
Lizy
|
Lizy provides SME and professional leasing solutions that are simple, quick, and inexpensive. LIZY wants to take the hassle out of leasing by offering transparent all-in prices, flexible contracts, and a selection of young, high-quality used cars that are immediately available. Sam Heymans and Vincent Castus, two young entrepreneurs, founded LIZYin 2019. | $9.3M / Oct 07, 2022 | |
|
Lizy
|
Lizy provides SME and professional leasing solutions that are simple, quick, and inexpensive. LIZY wants to take the hassle out of leasing by offering transparent all-in prices, flexible contracts, and a selection of young, high-quality used cars that are immediately available. Sam Heymans and Vincent Castus, two young entrepreneurs, founded LIZYin 2019. | $8.3M / Series A / Oct 07, 2022 | |
Itineris
|
Itineris develops and implements UMAX, a cloud-based CIS & CRM solution specifically designed for Utilities. UMAX leverages workflow automation and AI to easily manage everything from meter to cash, advanced revenue collection, assets, complex rates, conservation, marketing and campaign programs, and much more to ensure advanced customerengagement and streamlined business processes. UMAX is developed on the powerful Microsoft Dynamics 365 platform, and is delivered as a service in the Microsoft Azure Cloud. Founded in 2003, Itineris has an impressive implementation track record. Our customer base includes De Watergroep (Belgium), Eneco (the Netherlands), SSE (UK), Flogas (Ireland), The New York Department of Environmental Protection (US), Boston Water and Sewer Commission (US), and the City of Tallahassee (US), to name a few.With our software solutions, we want to empower utility professionals to play their part in the new world of energy and water. | $17.6M / Venture - Series Unknown / Apr 04, 2022 | |
SOPHiA GENETICS
|
SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and differentdiagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally. | $77M / Series E / Jan 04, 2019 | |
|
SOPHiA GENETICS
|
SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and differentdiagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally. | $30M / Series D / Sep 13, 2017 | |
|
Lizy
|
Lizy provides SME and professional leasing solutions that are simple, quick, and inexpensive. LIZY wants to take the hassle out of leasing by offering transparent all-in prices, flexible contracts, and a selection of young, high-quality used cars that are immediately available. Sam Heymans and Vincent Castus, two young entrepreneurs, founded LIZYin 2019. | $11.7M |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Alychlo invest in?
Alychlo invests primarily in CRM, Energy and Rental startups, most often at Series D and Venture - Series Unknown stage. Most of the 9 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Alychlo's check size?
Alychlo typically joins rounds of $30M–$32M at Series D and $12M–$18M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Alychlo participates in.
When did Alychlo last invest?
The most recent investment recorded for Alychlo closed in Aug 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
